Patent · US Active

Mutated organophosphorus acid anhydrolases and their uses thereof

US9587232B1 · kind B1 · utility

5Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 19, 2015
Grant dateMar 7, 2017
Priority date—
Expiry dateNov 19, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y301/08002
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is directed toward non-wild-type organophosphorus acid anhydrolases having three site mutations, method of production, and method of use to effectively degrade toxic chemicals such as N,N-diethyl-2-(methyl-(2-methylpropoxy)phosphoryl)sulfanylethanamine) (“VR”).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.